Cited by 228Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related DiseasesOccupational and environmental lung diseases

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program

Open access
Wang, Yi, Zhang, Lei, Wu, Guo-Rao, Zhou, Qing, Yue, Huihui, Rao, Li-Zong, Yuan, Ting, Mo, Biwen +13 more·2021·Science Advances

Abstract

Liposomes carrying MBD2 siRNA protect mice against BLM-induced lung injury and fibrosis by targeting macrophage M2 program.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.abb6075

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IPF patients are predominantly infiltrated by M2 macrophages during disease progression.

    “IPF patients are predominantly infiltrated by M2 macrophages during disease progression 12, 13.”

    From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [13]

    The Results section reports M2 macrophages in fibrotic lung tissue from patients with IPF, and the Discussion describes infiltrated M2 macrophages in fibrotic lungs. It does not establish that M2 macrophages predominate among infiltrating cells in IPF patients or track their infiltration during human disease progression; the reported link with progression comes from mice. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, Y., Zhang, L., Wu, G.-R., Zhou, Q., Yue, H., Rao, L.-Z., Yuan, T., Mo, B., Wang, F.-X., Chen, L.-M., Sun, F., Song, J., Xiong, F., Zhang, S., Yu, Q., Yang, P., Xu, Y., Zhao, J., Zhang, H., Xiong, W., & Wang, C.-Y.
Affiliations
  • Tongji Hospital (CN)
  • The Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave., Wuhan 430030, China.
  • Guilin Medical University (CN)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Zhang, Huilan
  • Xiong, Weining
  • Wang, Cong-Yi
Venue
Science Advances
Published
2021-01
Volume
7
Issue
1
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3107456091
Cited by
227
References
55
Citations by year
2026: 32 · 2025: 49 · 2024: 49 · 2023: 37 · 2022: 39 · 2021: 19 · 2020: 1
FWCI
23.54
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology (2016YFC1305002 and 2017YFC1309603)
  • National Natural Science Foundation of China (81530024, 9174920038, 81800068, 81920108009, 81770823 and 81670729)
  • NHC Drug Discovery Program (2017ZX09304022-07)
  • the Department of Science and Technology of Hubei Province (2017ACA096)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
MBD2, pulmonary fibrosis, M2 macrophages, macrophage polarization, siRNA, therapeutic target
MeSH terms
COVID-19, Animals, Bleomycin, Carcinoma, Non-Small-Cell Lung, DNA-Binding Proteins, Fibrosis, Gene Expression Regulation, Humans, Liposomes, Lung Neoplasms, Macrophages, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Scleroderma, Systemic, Signal Transduction, Lung Diseases, Interstitial, Mice, Knockout, Gene Expression Profiling, RNA, Small Interfering, Mice, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review